These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8652852)

  • 1. Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells.
    Breems DA; van Hennik PB; Kusadasi N; Boudewijn A; Cornelissen JJ; Sonneveld P; Ploemacher RE
    Blood; 1996 Jun; 87(12):5370-8. PubMed ID: 8652852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells.
    Breems DA; Blokland EA; Siebel KE; Mayen AE; Engels LJ; Ploemacher RE
    Blood; 1998 Jan; 91(1):111-7. PubMed ID: 9414274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
    Fruehauf S; Haas R; Conradt C; Murea S; Witt B; Möhle R; Hunstein W
    Blood; 1995 May; 85(9):2619-26. PubMed ID: 7537123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Moretti S; Dominici M; Punturieri M; Focarile E; Pauli S; Dabusti M; Tieghi A; Bacilieri M; Scapoli C; De Angeli C; Galluccio L; Castoldi G
    Exp Hematol; 2001 Dec; 29(12):1484-93. PubMed ID: 11750108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-conditioned media improve expansion of human primitive hematopoietic stem cells and progenitor cells.
    Breems DA; Blokland EA; Ploemacher RE
    Leukemia; 1997 Jan; 11(1):142-50. PubMed ID: 9001430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay.
    Breems DA; Blokland EA; Neben S; Ploemacher RE
    Leukemia; 1994 Jul; 8(7):1095-104. PubMed ID: 8035601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
    Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
    Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human accessory cells have a humoral bystander effect on CAFC growing on murine feeder.
    Mazini L; Wunder E; Sovalat H; Jung G; Bourderont D; Bachorz J; Bearenzung M; Zanetti C; Hénon P
    J Hematother Stem Cell Res; 2000 Oct; 9(5):749-57. PubMed ID: 11091499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of G-CSF-mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34+ cells but no loss of primitive haemopoietic progenitors.
    Kwekkeboom J; Buurman DE; van Hennik PB; Ploemacher RE; Loos HA; Slaper-Cortenbach IC
    Br J Haematol; 1997 Oct; 99(1):47-55. PubMed ID: 9359501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
    Haas R; Möhle R; Pförsich M; Fruehauf S; Witt B; Goldschmidt H; Hunstein W
    Blood; 1995 Apr; 85(7):1936-43. PubMed ID: 7535595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
    Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
    Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
    Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
    Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of the proliferative potential of highly enriched human primitive hematopoietic progenitor cells using a stroma-free limiting dilution assay with automated scoring.
    Young JC; Wu S; Travis M; Luens KM; Osborne L; Scollay R; Hill B
    Cytotherapy; 1999; 1(2):147-56. PubMed ID: 19746592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates.
    Andrews RG; Briddell RA; Knitter GH; Rowley SD; Appelbaum FR; McNiece IK
    Blood; 1995 Jan; 85(1):15-20. PubMed ID: 7528562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.